Literature DB >> 18474523

Signalling mechanisms underlying the metabolic and other effects of adipokines on the heart.

Morris Karmazyn1, Daniel M Purdham, Venkatesh Rajapurohitam, Asad Zeidan.   

Abstract

Adipokines represent a family of proteins released by adipocytes that affect various biological processes including metabolism, satiety, inflammation, and cardiovascular function. The first adipokine to be identified is leptin, a product of the obesity gene whose primary function is to act as a satiety factor. However, it is now recognized that leptin and many of the newly discovered adipokines produce effects on numerous organ systems including the heart. Indeed, various adipokines including leptin, adiponectin, and apelin exert potent and diverse cardiovascular effects which are mediated by their specific receptors and involve complex and multifaceted cell-signalling pathways. Among these are effects on the heart as well as blood pressure where leptin has been proposed to potentially contribute to obesity-related hypertension. In this review, we focus primarily on the diverse effects of adipokines on the heart and discuss the potential cell-signalling mechanisms underlying their actions. The potential role of adipokines in the regulation of cardiac metabolism and function is discussed. Discussion is also presented on the emerging role, both deleterious and salutary, of various adipokines in heart disease with an examination of the possible underlying mechanisms which contribute to these effects.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18474523     DOI: 10.1093/cvr/cvn115

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  35 in total

1.  Circulating Adiponectin Levels Following Treatment Can Predict Late Clinical Outcomes in Chronic Heart Failure.

Authors:  Ho-Ping Yu; Hsu-Lung Jen; Wei-Hsian Yin; Jeng Wei
Journal:  Acta Cardiol Sin       Date:  2017-03       Impact factor: 2.672

2.  Higher circulating adiponectin levels are associated with increased risk of atrial fibrillation in older adults.

Authors:  Fima Macheret; Traci M Bartz; Luc Djousse; Joachim H Ix; Kenneth J Mukamal; Susan J Zieman; David S Siscovick; Russell P Tracy; Susan R Heckbert; Bruce M Psaty; Jorge R Kizer
Journal:  Heart       Date:  2015-04-08       Impact factor: 5.994

3.  Adiponectin circulating levels and 10-year (2002-2012) cardiovascular disease incidence: the ATTICA Study.

Authors:  Ioannis Kyrou; Olga Tsantarlioti; Demosthenes B Panagiotakos; Constantine Tsigos; Ekavi Georgousopoulou; Christina Chrysohoou; Ioannis Skoumas; Dimitrios Tousoulis; Christodoulos Stefanadis; Christos Pitsavos
Journal:  Endocrine       Date:  2017-10-16       Impact factor: 3.633

Review 4.  Mechanisms of heart failure in obesity.

Authors:  Imo A Ebong; David C Goff; Carlos J Rodriguez; Haiying Chen; Alain G Bertoni
Journal:  Obes Res Clin Pract       Date:  2014-01-06       Impact factor: 2.288

Review 5.  Diabetic cardiomyopathy: signaling defects and therapeutic approaches.

Authors:  Joseph S Dobrin; Djamel Lebeche
Journal:  Expert Rev Cardiovasc Ther       Date:  2010-03

6.  Obese-insulin resistance accelerates and aggravates cardiometabolic disorders and cardiac mitochondrial dysfunction in estrogen-deprived female rats.

Authors:  Sivaporn Sivasinprasasn; Piangkwan Sa-Nguanmoo; Wasana Pratchayasakul; Sirinart Kumfu; Siriporn C Chattipakorn; Nipon Chattipakorn
Journal:  Age (Dordr)       Date:  2015-03-20

7.  Bioinformatic identification and characterization of human endothelial cell-restricted genes.

Authors:  Manoj Bhasin; Lei Yuan; Derin B Keskin; Hasan H Otu; Towia A Libermann; Peter Oettgen
Journal:  BMC Genomics       Date:  2010-05-28       Impact factor: 3.969

8.  A high-fat diet increases adiposity but maintains mitochondrial oxidative enzymes without affecting development of heart failure with pressure overload.

Authors:  David J Chess; Ramzi J Khairallah; Karen M O'Shea; Wenhong Xu; William C Stanley
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-09-18       Impact factor: 4.733

Review 9.  Inflammation Markers in Type 2 Diabetes and the Metabolic Syndrome in the Pediatric Population.

Authors:  Thomas Reinehr; Christian Ludwig Roth
Journal:  Curr Diab Rep       Date:  2018-10-18       Impact factor: 4.810

Review 10.  Epicardial adipose tissue as a metabolic transducer: role in heart failure and coronary artery disease.

Authors:  Vaibhav B Patel; Saumya Shah; Subodh Verma; Gavin Y Oudit
Journal:  Heart Fail Rev       Date:  2017-11       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.